- Filed
- May 11, 2015 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2015 · May 8, 2015 | 86.93M sh |
| Shares Diluted | Q1 2015 · Mar 31, 2015 | 121.5M sh |
| Shares Diluted | Q1 2015 · Mar 31, 2014 | 119.24M sh |
| Capex | Q1 2015 · Mar 31, 2015 | $1.2M |
| Capex | Q1 2015 · Mar 31, 2014 | $1.57M |
| Cash And Equivalents | Q1 2015 · Mar 31, 2015 | $65.25M |
| Cash And Equivalents | Q1 2015 · Dec 31, 2014 | $70.81M |
| Cash And Equivalents | Q1 2015 · Mar 31, 2014 | $54.12M |
| Cash And Equivalents | Q1 2015 · Dec 31, 2013 | $43.58M |
| Stockholders Equity | Q1 2015 · Mar 31, 2015 | $37.28M |
| Stockholders Equity | Q1 2015 · Dec 31, 2014 | $33.27M |
| Current Liabilities | Q1 2015 · Mar 31, 2015 | $44.12M |
| Current Liabilities | Q1 2015 · Dec 31, 2014 | $48.08M |
| Total Liabilities | Q1 2015 · Mar 31, 2015 | $58.46M |
| Total Liabilities | Q1 2015 · Dec 31, 2014 | $64.15M |
| Current Assets | Q1 2015 · Mar 31, 2015 | $77.7M |
| Current Assets | Q1 2015 · Dec 31, 2014 | $79.92M |
| Total Assets | Q1 2015 · Mar 31, 2015 | $98.73M |
| Total Assets | Q1 2015 · Dec 31, 2014 | $100.42M |
| Eps Diluted | Q1 2015 · Mar 31, 2015 | $0.02 |
| Eps Diluted | Q1 2015 · Mar 31, 2014 | $0.02 |
| Eps Basic | Q1 2015 · Mar 31, 2015 | $0.03 |
| Eps Basic | Q1 2015 · Mar 31, 2014 | $0.02 |
| Sga Expense | Q1 2015 · Mar 31, 2015 | $5.92M |
| Sga Expense restated | Q1 2015 · Mar 31, 2014 | $6.29M |
| Rd Expense | Q1 2015 · Mar 31, 2015 | $2.95M |
| Rd Expense restated | Q1 2015 · Mar 31, 2014 | $1.41M |
| Net Income | Q1 2015 · Mar 31, 2015 | $3.09M |
| Net Income | Q1 2015 · Mar 31, 2014 | $1.94M |
| Operating Income | Q1 2015 · Mar 31, 2015 | $4.93M |
| Operating Income | Q1 2015 · Mar 31, 2014 | $3.19M |
| Gross Profit | Q1 2015 · Mar 31, 2015 | $18.43M |
| Gross Profit restated | Q1 2015 · Mar 31, 2014 | $15.35M |
| Cost Of Revenue | Q1 2015 · Mar 31, 2015 | $4.4M |
| Cost Of Revenue restated | Q1 2015 · Mar 31, 2014 | $3.78M |